Senti Biosciences Holdings (SNTI) EBIT Margin (2021 - 2023)
Senti Biosciences Holdings (SNTI) posted quarterly EBIT Margin of 12981.07% for Q3 2023, down 1200824.0% year-over-year from N/an in Q3 2022, and down 487.17% quarter-over-quarter from 2210.77% in Q2 2023.
Senti Biosciences Holdings (SNTI) EBIT Margin (2021 - 2023) Analysis & Trends
Senti Biosciences Holdings' EBIT Margin history runs 3 years deep, the most recent figure standing at 12981.07% for Q3 2023.
- In Q3 2023, EBIT Margin fell 1200824.0% year-over-year to 12981.07%; the TTM figure through Jun 2024 stood at 27287.28% (down 2554844.0% YoY), while the FY2025 annual figure was 312631.82%, changed N/A from the prior year.
- EBIT Margin for Q3 2023 stood at 12981.07%, down from 2210.77% in the prior quarter.
- The five-year high for EBIT Margin was 972.82% in Q3 2022, with the low at 28464.41% in Q4 2022.
- The 3-year median for EBIT Margin is 1180.24% (2021), against an average of 5184.97%.
- Peak annual rise in EBIT Margin reached 6281 bps in 2022, while the deepest fall reached 2726754 bps in 2022.
- Senti Biosciences Holdings' EBIT Margin stood at 1196.86% in 2021, then tumbled by 2278 bps to 28464.41% in 2022, then surged by 54 bps to 12981.07% in 2023.
- Business Quant data shows SNTI's EBIT Margin at 12981.07% in Q3 2023, 2210.77% in Q2 2023, and 1163.61% in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 37.40% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 30.15% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 32.54% |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -562.07% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 19.06% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 17.93% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -35.57% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.36% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 19.75% |
| 10 | Senti Biosciences Holdings | 12.06 Mn | 12.06 Mn | - | -85,229.41% |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -12,981.07% |
| Jun 30, 2023 | -2,210.77% |
| Mar 31, 2023 | -1,163.61% |
| Dec 31, 2022 | -28,464.41% |
| Sep 30, 2022 | -972.82% |
| Jun 30, 2022 | -1,603.17% |
| Mar 31, 2022 | -1,065.04% |
| Dec 31, 2021 | -1,196.86% |
| Sep 30, 2021 | -1,035.63% |
| Jun 30, 2021 | -1,156.30% |